Stem Cell & Regenerative Medicine:

Tuesday, September 20, 2011 (7:30 AM - 12:30 PM)

Today and Tomorrow

Stem Cell Biology and Regenerative Medicine are among the most promising fields in the history of medicine. With stem cells, scientists see opportunities to make great strides in treating diseases and injuries, such as heart disease, cancer, diabetes, neurodegenerative diseases, spinal cord injury, blindness, among others.

This half-day symposium will present an overview of some of the most cutting-edge stem cell research projects and discuss the best ways to generate tomorrow’s companies that will develop corresponding transformative therapies. 


Session One:  Seattle as a stem cell & regenerative medicine hub

Keynote speaker – Perspectives on Seattle’s strengths
Chuck Murry, MD, PhD, Co-Director, ISCRM; Pathology & Bioengineering Professor, University of Washington

Panel – Today’s tech for tomorrow’s start-ups 
Moderated by:  Irv Bernstein, MD, Head of the Pediatric Oncology Program, Fred Hutchinson Cancer Research Center; Chief of the Division, Pediatric Hematology/Oncology, University of Washington School of Medicine

  • C. Anthony Blau, MD, Co-Director, ISCRM; Professor, Department of Medicine, Division of Hematology
  • Philip Horner, PhD, Associate Professor, Neurological Surgery, University of Washington
  • Michael Laflamme, MD, PhD, Assistant Professor, Department of Pathology Center for Cardiovascular, University of Washington
  • Chuck Murry, MD, PhD, Co-Director, ISCRM, Pathology & Bioengineering Professor, University of Washington
  • Tom Reh, PhD, Professor, Biological Structure, University of Washington
  • David Russell, MD, PhD, Professor, Hematology, Medicine, University of Washington
  • Andrew Scharenberg, MD, Seattle Children's Attending Physician, Immunodeficiency Clinic and Inpatient Immunology Service; Professor, Pediatrics; Adjunct Professor, Immunology, Seattle Children's Research Institute
  • Qiang Tian, MD, PhD, Senior Research Scientist, Stem Cell Group Leader, Institute for Systems Biology

Session Two:  Collaborative funding and commercialization

Panel – Recipes for success
Moderated by: Andrew Serafini, PhD, Partner, Fenwick & West, LLP

  • Ron Berenson, MD, Entrepreneur-in-Residence, University of Washington C4C; Medical Oncologist
  • Joseph Gold, PhD,  Senior Director, Neurobiology and Cell Therapies Research, Geron Corporation
  • John Mendlein, PhD, Executive Chairman, Fate Therapeutics
  • Tom Vihtelic, DVM, PhD, Director, Experimental Therapeutics, MPI Research
  • Carl Weissman, President & CEO, Accelerator Corporation; Managing Director, OVP Venture Partners

What You’ll Learn:

  • Washington-based research institutions are hosting cutting-edge and highly relevant stem cell and regenerative medicine research
  • Overview of the projects that might become tomorrow’s start-ups in stem cell research
  • Washington state position in projected global markets for stem cell research and therapy development
  • What makes our region attractive to the eyes of biotechs and investors for partnership/investment

Who Should Attend:

  • Business Development Executives
  • Investors
  • Policy Makers
  • Research Scientists
  • Any interested parties
Registration Fees:
WBBA Member-     $75.00                    
Non-Member-        $125.00                    
Academia, Nonprofit, Student-     $40.00

Thank you to our sponsors:

Thank you to our host:

University of Washington
The Institute for Stem Cell and Regenerative Medicine (ISCRM)

© 2012 Washington Biotechnology & Biomedical Association

Powered by